Circulating Endothelial Cells in Refractory Pulmonary Hypertension in Children: Markers of Treatment Efficacy and Clinical Worsening
Article 2013 en
Authors
ML
Marilyne Lévy
DB
Damien Bonnet
LM
Laëtitia Mauge
Abstract
1 min read
CECs might be useful as a biomarker during follow-up of pediatric iPAH and PAH-CHD to assess response to treatment and to anticipate clinical worsening.
N. Bacha, N. Bacha, Marilyne Lévy, Marilyne Lévy, Coralie L. Guérin, Coralie L. Guérin, Bernard Le Bonniec, Bernard Le Bonniec, Annie Harroche, Annie Harroche, Isabelle Szézépanski, Isabelle Szézépanski, Jean Marie Renard, Jean Marie Renard, Pascale Gaussem, Pascale Gaussem, Dominique Israël‐Biet, Dominique Israël‐Biet, Chantal M. Boulanger, Chantal M. Boulanger, David M. Smadja, David M. Smadja
N. Bacha, N. Bacha, Marilyne Lévy, Marilyne Lévy, Coralie L. Guérin, Coralie L. Guérin, Bernard Le Bonniec, Bernard Le Bonniec, Annie Harroche, Annie Harroche, Pascale Gaussem, Pascale Gaussem, Dominique Israël‐Biet, Dominique Israël‐Biet, Chantal M. Boulanger, Chantal M. Boulanger, David M. Smadja, David M. Smadja
Discussion(0)
No comments yet. Be the first to comment.